LUMIBIRD
ISIN: FR0000038242 | Ticker: LBIRD | LEI: 969500MLJC3ZSZP4L019
Country: France
With 50 years of experience and expertise in 3 key technologies – solid-state lasers, laser diodes and fiber lasers – the group designs, manufactures and markets high performance lasers for the scientific (laboratories and universities), industrial (manufacturing, defense, LiDAR sensors), and medical (ophthalmology).
Created through the business combination between the Keopsys and Quantel Groups in October 2017, LUMIBIRD is a mid-size firm with more than 800 employees, revenues of over 162.5 M€, and offices in Europe, North America, China, Japan and Australia.
Our mission: popularizing lasers
Our business: industrializing laser production
1970
Served areaWorlwide
Headcount800
Headquarters2 Rue du Paul Sabatier, 22300 Lannion – France
| Line item in (eur) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Assets | N/A | 305,430,000.00 | 347,622,000.00 | 372,044,000.00 |
| Noncurrent Assets | N/A | 143,121,000.00 | 164,751,000.00 | 184,917,000.00 |
| Property Plant And Equipment | N/A | 24,743,000.00 | 28,166,000.00 | 39,687,000.00 |
| Goodwill | N/A | 69,214,000.00 | 70,263,000.00 | 69,941,000.00 |
| Intangible Assets Other Than Goodwill | N/A | 39,976,000.00 | 47,321,000.00 | 53,414,000.00 |
| Deferred Tax Assets | N/A | 2,042,000.00 | 1,028,000.00 | 2,442,000.00 |
| Current Tax Assets Noncurrent | N/A | 5,099,000.00 | 7,617,000.00 | 8,477,000.00 |
| Other Noncurrent Nonfinancial Assets | N/A | 0.00 | 0.00 | 0.00 |
| Current Assets | N/A | 162,309,000.00 | 182,872,000.00 | 187,127,000.00 |
| Inventories | N/A | 37,202,000.00 | 45,848,000.00 | 65,403,000.00 |
| Current Tax Assets Current | N/A | 2,754,000.00 | 189,000.00 | 354,000.00 |
| Other Current Financial Assets | N/A | 32,875,000.00 | 30,778,000.00 | 47,904,000.00 |
| Other Current Nonfinancial Assets | N/A | 9,148,000.00 | 8,929,000.00 | 11,789,000.00 |
| Cash and cash equivalents | N/A | 80,330,000.00 | 97,128,000.00 | 61,677,000.00 |
| Equity And Liabilities | N/A | 305,430,000.00 | 347,622,000.00 | 372,044,000.00 |
| Equity | 124,946,000.00 | 164,084,000.00 | 181,327,000.00 | 193,438,000.00 |
| Issued Capital | N/A | 22,467,000.00 | 22,467,000.00 | 22,467,000.00 |
| Retained Earnings Profit Loss For Reporting Period | N/A | N/A | 13,858,000.00 | 11,353,000.00 |
| Retained Earnings Excluding Profit Loss For Reporting Period | N/A | N/A | 143,544,000.00 | 158,550,000.00 |
| Equity Attributable To Owners Of Parent | N/A | 164,085,000.00 | 181,327,000.00 | 193,438,000.00 |
| Noncontrolling Interests | N/A | 0.00 | 0.00 | 0.00 |
| Noncurrent Liabilities | N/A | 83,980,000.00 | 108,356,000.00 | 58,760,000.00 |
| Noncurrent Provisions For Employee Benefits | N/A | 2,632,000.00 | 3,113,000.00 | 2,666,000.00 |
| Other Longterm Provisions | N/A | 416,000.00 | 34,000.00 | 34,000.00 |
| Deferred Tax Liabilities | N/A | 603,000.00 | 869,000.00 | 2,576,000.00 |
| Other Noncurrent Financial Liabilities | N/A | 3,904,000.00 | 1,071,000.00 | 0.00 |
| Other Noncurrent Nonfinancial Liabilities | N/A | 4,903,000.00 | 5,409,000.00 | 4,866,000.00 |
| Longterm Borrowings | N/A | 71,522,000.00 | 97,860,000.00 | 48,618,000.00 |
| Current Liabilities | N/A | 57,366,000.00 | 57,938,000.00 | 119,845,000.00 |
| Current Provisions | N/A | 730,000.00 | 1,258,000.00 | 1,573,000.00 |
| Current Tax Liabilities Current | N/A | 737,000.00 | 883,000.00 | 859,000.00 |
| Other Current Financial Liabilities | N/A | 16,957,000.00 | 19,093,000.00 | 29,272,000.00 |
| Other Current Nonfinancial Liabilities | N/A | 22,153,000.00 | 22,532,000.00 | 22,579,000.00 |
| Current Borrowings And Current Portion Of Noncurrent Borrowings | N/A | 16,789,000.00 | 14,172,000.00 | 65,562,000.00 |
| Line item in (eur) | 01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
|---|---|---|---|
| Other Revenue | 2,776,000.00 | 3,918,000.00 | 3,335,000.00 |
| Revenue From Contracts With Customers | 126,729,000.00 | 162,468,000.00 | 190,959,000.00 |
| Raw Materials And Consumables Used | 49,958,000.00 | 59,190,000.00 | 73,038,000.00 |
| Services Expense | 14,894,000.00 | 19,157,000.00 | 24,498,000.00 |
| Employee Benefits Expense | 39,257,000.00 | 53,594,000.00 | 63,758,000.00 |
| Depreciation And Amortisation Expense | 9,382,000.00 | 12,033,000.00 | 14,305,000.00 |
| Tax Expense Other Than Income Tax Expense | 1,737,000.00 | 1,802,000.00 | 1,662,000.00 |
| Profit Loss From Operating Activities | 8,662,000.00 | 19,130,000.00 | 17,261,000.00 |
| Income Tax Expense Continuing Operations | 1,553,000.00 | 3,745,000.00 | 3,084,000.00 |
| Profit (loss) | 5,638,000.00 | 13,858,000.00 | 11,353,000.00 |
| Profit Loss Attributable To Owners Of Parent | 5,638,000.00 | 13,858,000.00 | 11,353,000.00 |
| Profit Loss Attributable To Noncontrolling Interests | 0.00 | 0.00 | 0.00 |
| Line item in (eur) | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|
| Profit (loss) | 5,638,000.00 | 13,858,000.00 | 11,353,000.00 |
| Adjustments For Income Tax Expense | 1,554,000.00 | 3,745,000.00 | 3,084,000.00 |
| Adjustments For Finance Costs | 1,388,000.00 | 2,261,000.00 | 3,344,000.00 |
| Other Adjustments For Noncash Items | -310,000.00 | 1,324,000.00 | 1,323,000.00 |
| Adjustments For Losses Gains On Disposal Of Noncurrent Assets | 176,000.00 | 10,000.00 | -3,894,000.00 |
| Income Taxes Paid Refund Classified As Operating Activities | -1,076,000.00 | -1,830,000.00 | -512,000.00 |
| Cash Flows From Used In Operating Activities | 13,123,000.00 | 26,575,000.00 | 1,427,000.00 |
| Cash Flows From Used In Investing Activities | -67,137,000.00 | -28,633,000.00 | -29,338,000.00 |
| Proceeds From Borrowings Classified As Financing Activities | 57,091,000.00 | 38,287,000.00 | 15,210,000.00 |
| Repayments Of Borrowings Classified As Financing Activities | 3,868,000.00 | 18,082,000.00 | 18,767,000.00 |
| Interest Paid Classified As Financing Activities | 1,401,000.00 | 2,207,000.00 | 2,926,000.00 |
| Cash Flows From Used In Financing Activities | 84,756,000.00 | 18,205,000.00 | -7,889,000.00 |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | -617,000.00 | 640,000.00 | 173,000.00 |
| Increase (decrease) in cash and cash equivalents after effect of exchange rate changes | 30,125,000.00 | 16,787,000.00 | -35,628,000.00 |
| Cash and cash equivalents | 80,330,000.00 | 97,128,000.00 | 61,677,000.00 |
Please note that some sums might not add up.
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 05.07.23 | None | Other | Sell | EUR 729,000.00 |
FR0000038242
LEI969500MLJC3ZSZP4L019
SectorHealth Care Equipment & Services
IndustryHealth Care Equipment & Supplies
Sub-IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.